Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

21Food Online Expo

Thursday, April 30, 2020

Affected by COVID all the exhibitions be postponed or canceled To reduce the impact for food industry FOOD will held a Food Online Expo This was felt to be the best and safest course of action after careful consideration of evolving COVID pandemic de...

Marker Therapeutics Receives FDA Orphan Drug Designation for its Multi-Antigen Targeted T Cell Therapy for Acute Myeloid Leukemia

Thursday, April 30, 2020

Marker Therapeutics Inc a clinicalstage immunooncology company specializing in the development of nextgeneration T cellbased immunotherapies for the treatment of hematological malignancies and solid tumor indications announced that the United States...

Neuraptive Therapeutics Announces FDA Approval of IND Application for New Drug NTX-001 for Treatment of Patients with Peripheral Nerve Impairment

Thursday, April 30, 2020

Neuraptive Therapeutics Inc Neuraptive is a clinical stage biotechnology company dedicated to the development of new therapies and medical products to address the treatment of peripheral nerve damage PNI Unmet needs The company announced today that t...

ProteoGenix Announces a New Human COVID-19 Antibody Library to Accelerate the Discovery of Potent and Urgently Needed Solutions

Wednesday, April 29, 2020

ProteoGenix a global leader in antibody production is pleased to announce the first Human Immune COVID library for the fast discovery of potent antibodies against SARSCoV Highly sensitive and specific antibodies are critical for the development of di...

CytoSMART to donate 100 live-cell imaging systems to assist COVID-19 researchers

Wednesday, April 29, 2020

CytoSMART Technologies is to donate mini livecell imaging systems to researchers in high containment labs worldwide Labs working to combat COVID will benefit from this initiative as CytoSMART aims to reduce the huge workload currently facing researc...

BioEclipse Receives FDA Clearance of Investigational New Drug Application for CRX100

Wednesday, April 29, 2020

BioEclipse Therapeutics BioEclipse a private clinicalstage biopharmaceutical company developing firstinclass curative immunooncology therapeutics announced today that the US Food and Drug Administration has cleared the Investigational New Drug IND ap...

BerGenBio's Bemcentinib Selected to Be Fast-tracked As Potential Treatment for COVID-19 Through New National UK Government Clinical Trial Initiative

Wednesday, April 29, 2020

BerGenBio ASA a clinicalstage biopharmaceutical company developing novel selective AXL kinase inhibitors for unmet medical need announces that bemcentinib has been selected as the first potential treatment to be fasttracked in a new UK national multi...

ROME Therapeutics Launches to Develop Novel Therapies for Cancer and Autoimmune Diseases by Harnessing the Power of the Repeatome

Tuesday, April 28, 2020

ROME Therapeutics a biotechnology company harnessing the power of the repeatome in drug development launched today with million in Series A funding from GV ARCH Venture Partners and Partners Innovation Fund ROME was founded to discover and develop n...

Vertex Pharmaceuticals and Affinia Therapeutics Establish Multi-Year Collaboration to Discover and Develop Novel AAV Capsids for Genetic Therapies

Tuesday, April 28, 2020

Vertex Pharmaceuticals Incorporated and Affinia Therapeutics announced today that the two companies have entered into a strategic research collaboration to engineer novel adenoassociated virus AAV capsids to deliver transformative genetic therapies t...

Calliditas provides a corporate business update in the context of the Covid-19 pandemic

Monday, April 27, 2020

Calliditas Therapeutics AB publ provided an update on its business activities and financial position as well as the initiatives announced to continue to build its organization amid the evolving COVID pandemic all while promoting the continuity of the...